死亡辅助的药理学:从数据库分析到基于证据的最佳实践
Patrick Macmillan1, Susan Hughes2, Angelique Loscar3
1Department of Internal Medicine, University of California San Francisco Fresno, Fresno, California, USA.
Journal of palliative medicine
|January 28, 2025
概括
分析了医疗辅助死亡 (MAID) 药物治疗方案的有效性. 虽然单一的镇静剂提供了最快的中位死亡时间,但最近的镇静剂/心脏毒素组合减少了长期死亡.
科学领域:
- 医学伦理 医学伦理
- 抚慰性护理是一种缓解性护理.
- 药理学 药理学是指药理学的学科.
背景情况:
- 死亡医疗援助 (MAID) 在10个州和华盛顿特区合法,但基于证据的护理,特别是关于药物的护理,仍然缺乏研究.
- 围绕MAID的伦理辩论广泛,但关于药物疗效的经验数据有限.
研究的目的:
- 调查四种常见的MAID药物治疗方案的疗效.
- 为了比较仅用镇静剂与镇静剂/心脏毒素组合方案,使用睡眠时间和死亡时间作为疗效指标.
主要方法:
- 来自四个组织的3,332份死亡报告 (2009-2023) 的非身份化数据的独立二次分析.
- 一个仅用镇静剂的方案与三个不同的镇静剂/心脏毒素组合方案的比较.
- 计算每个协议的睡眠时间和死亡时间的描述统计数据.
主要成果:
- 仅服用镇静剂的方案中死亡的中位时间最快 (0.4小时),但偶尔会出现长期异常值.
- 两种镇静剂/心脏毒素组合显示死亡的中位时间为0.8小时.
- 从2018-2023年,药物转换表明,组合减少了较长时间死亡的发生率,特别是极端异常值.
结论:
- 虽然仅用镇静剂就证明了最快的死亡中位数时间,但最新的镇静剂/心脏毒素协议提供了可接受的死亡中位数时间 (0.8小时),较少的长期死亡异常值.
- 这项研究提供了MAID药物治疗方案疗效的首次分析,突出了特定组合对减少长期死亡的影响.
相关概念视频
01:30Ethical Dilemmas II
916
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
916
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:22Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
01:03Drug Control Governance: Regulatory Bodies and Their Impact
138
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
138
01:27Ethical Issues
844
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
844
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37